Cargando…
In silico analyses and design of a chimeric protein containing epitopes of SpaC, PknG, NanH, and SodC proteins for the control of caseous lymphadenitis
ABSTRACT: Caseous lymphadenitis (CLA) is an infectious disease that affects goats and sheep causing drastic impacts on milk and meat production and is caused by Corynebacterium pseudotuberculosis. The disease can be prevented through vaccination but currently, vaccines demonstrate limited efficacy c...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497191/ https://www.ncbi.nlm.nih.gov/pubmed/34622335 http://dx.doi.org/10.1007/s00253-021-11619-x |
_version_ | 1784579901431480320 |
---|---|
author | Silva, Mara Thais de Oliveira de Pinho, Rodrigo Barros Bezerra, Francisco Silvestre Brilhante Scholl, Nicole Ramos Moron, Luiza Domingues Alves, Mirna Samara Dié Woloski, Rafael dos Santos Kremer, Frederico Schmitt Borsuk, Sibele |
author_facet | Silva, Mara Thais de Oliveira de Pinho, Rodrigo Barros Bezerra, Francisco Silvestre Brilhante Scholl, Nicole Ramos Moron, Luiza Domingues Alves, Mirna Samara Dié Woloski, Rafael dos Santos Kremer, Frederico Schmitt Borsuk, Sibele |
author_sort | Silva, Mara Thais de Oliveira |
collection | PubMed |
description | ABSTRACT: Caseous lymphadenitis (CLA) is an infectious disease that affects goats and sheep causing drastic impacts on milk and meat production and is caused by Corynebacterium pseudotuberculosis. The disease can be prevented through vaccination but currently, vaccines demonstrate limited efficacy consequently leading to a need for the development of new ones. Here, we described the in silico development of a new chimeric protein constructed with epitopes identified from the sequences of the genes nanH, pknG, spaC, and sodC, previously described as potential vaccinal targets against C. pseudotuberculosis. The chimera was expressed, purified, and its immunogenicity was evaluated using sera of immunized mice. Results indicate the chimeric protein was able to stimulate antibody production. Additionally, analysis using serum from naturally infected goats showed that the protein is recognized by sera from these animals, indicating the possibility for using this chimera in new diagnostic methods. KEY POINTS: • The chimera was expressed with 52 kDa and a yield of 7 mg/L after purification. • The chimera was recognized by the sera of animals immunized with this formulation. • Chimera reacted with the serum of goats naturally infected with C. pseudotuberculosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00253-021-11619-x. |
format | Online Article Text |
id | pubmed-8497191 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-84971912021-10-08 In silico analyses and design of a chimeric protein containing epitopes of SpaC, PknG, NanH, and SodC proteins for the control of caseous lymphadenitis Silva, Mara Thais de Oliveira de Pinho, Rodrigo Barros Bezerra, Francisco Silvestre Brilhante Scholl, Nicole Ramos Moron, Luiza Domingues Alves, Mirna Samara Dié Woloski, Rafael dos Santos Kremer, Frederico Schmitt Borsuk, Sibele Appl Microbiol Biotechnol Biotechnologically Relevant Enzymes and Proteins ABSTRACT: Caseous lymphadenitis (CLA) is an infectious disease that affects goats and sheep causing drastic impacts on milk and meat production and is caused by Corynebacterium pseudotuberculosis. The disease can be prevented through vaccination but currently, vaccines demonstrate limited efficacy consequently leading to a need for the development of new ones. Here, we described the in silico development of a new chimeric protein constructed with epitopes identified from the sequences of the genes nanH, pknG, spaC, and sodC, previously described as potential vaccinal targets against C. pseudotuberculosis. The chimera was expressed, purified, and its immunogenicity was evaluated using sera of immunized mice. Results indicate the chimeric protein was able to stimulate antibody production. Additionally, analysis using serum from naturally infected goats showed that the protein is recognized by sera from these animals, indicating the possibility for using this chimera in new diagnostic methods. KEY POINTS: • The chimera was expressed with 52 kDa and a yield of 7 mg/L after purification. • The chimera was recognized by the sera of animals immunized with this formulation. • Chimera reacted with the serum of goats naturally infected with C. pseudotuberculosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00253-021-11619-x. Springer Berlin Heidelberg 2021-10-08 2021 /pmc/articles/PMC8497191/ /pubmed/34622335 http://dx.doi.org/10.1007/s00253-021-11619-x Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Biotechnologically Relevant Enzymes and Proteins Silva, Mara Thais de Oliveira de Pinho, Rodrigo Barros Bezerra, Francisco Silvestre Brilhante Scholl, Nicole Ramos Moron, Luiza Domingues Alves, Mirna Samara Dié Woloski, Rafael dos Santos Kremer, Frederico Schmitt Borsuk, Sibele In silico analyses and design of a chimeric protein containing epitopes of SpaC, PknG, NanH, and SodC proteins for the control of caseous lymphadenitis |
title | In silico analyses and design of a chimeric protein containing epitopes of SpaC, PknG, NanH, and SodC proteins for the control of caseous lymphadenitis |
title_full | In silico analyses and design of a chimeric protein containing epitopes of SpaC, PknG, NanH, and SodC proteins for the control of caseous lymphadenitis |
title_fullStr | In silico analyses and design of a chimeric protein containing epitopes of SpaC, PknG, NanH, and SodC proteins for the control of caseous lymphadenitis |
title_full_unstemmed | In silico analyses and design of a chimeric protein containing epitopes of SpaC, PknG, NanH, and SodC proteins for the control of caseous lymphadenitis |
title_short | In silico analyses and design of a chimeric protein containing epitopes of SpaC, PknG, NanH, and SodC proteins for the control of caseous lymphadenitis |
title_sort | in silico analyses and design of a chimeric protein containing epitopes of spac, pkng, nanh, and sodc proteins for the control of caseous lymphadenitis |
topic | Biotechnologically Relevant Enzymes and Proteins |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497191/ https://www.ncbi.nlm.nih.gov/pubmed/34622335 http://dx.doi.org/10.1007/s00253-021-11619-x |
work_keys_str_mv | AT silvamarathaisdeoliveira insilicoanalysesanddesignofachimericproteincontainingepitopesofspacpkngnanhandsodcproteinsforthecontrolofcaseouslymphadenitis AT depinhorodrigobarros insilicoanalysesanddesignofachimericproteincontainingepitopesofspacpkngnanhandsodcproteinsforthecontrolofcaseouslymphadenitis AT bezerrafranciscosilvestrebrilhante insilicoanalysesanddesignofachimericproteincontainingepitopesofspacpkngnanhandsodcproteinsforthecontrolofcaseouslymphadenitis AT schollnicoleramos insilicoanalysesanddesignofachimericproteincontainingepitopesofspacpkngnanhandsodcproteinsforthecontrolofcaseouslymphadenitis AT moronluizadomingues insilicoanalysesanddesignofachimericproteincontainingepitopesofspacpkngnanhandsodcproteinsforthecontrolofcaseouslymphadenitis AT alvesmirnasamaradie insilicoanalysesanddesignofachimericproteincontainingepitopesofspacpkngnanhandsodcproteinsforthecontrolofcaseouslymphadenitis AT woloskirafaeldossantos insilicoanalysesanddesignofachimericproteincontainingepitopesofspacpkngnanhandsodcproteinsforthecontrolofcaseouslymphadenitis AT kremerfredericoschmitt insilicoanalysesanddesignofachimericproteincontainingepitopesofspacpkngnanhandsodcproteinsforthecontrolofcaseouslymphadenitis AT borsuksibele insilicoanalysesanddesignofachimericproteincontainingepitopesofspacpkngnanhandsodcproteinsforthecontrolofcaseouslymphadenitis |